|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Mar 22, 2004 |
Title |
Gene expression data from entire liver sections from 0.29% CA-treated rats |
Sample type |
RNA |
|
|
Source name |
entire liver sections from 0.29% CA-treated rats
|
Organism |
Rattus norvegicus |
Extracted molecule |
total RNA |
|
|
Description |
Liver sections from F344 rats treated with Clofibric Acid (CA) (0, 0.29 or 0.54 %) Keywords = Laser Capture Microdissection, Clofibric-Acid
|
|
|
Submission date |
Oct 01, 2003 |
Last update date |
May 28, 2005 |
Contact name |
Cecile Michel |
E-mail(s) |
[email protected]
|
Phone |
0(0 33)1 58 93 35 76
|
Organization name |
Aventis Pharma France
|
Department |
Drug Safety Evaluation
|
Lab |
Toxicogenomic
|
Street address |
13, quai Jules Guesdes
|
City |
Vitry sur Seine |
ZIP/Postal code |
94403 |
Country |
France |
|
|
Platform ID |
GPL85 |
Series (1) |
GSE691 |
Expression Profiles of Rats Treated with Clofibric Acid: Comparison of Whole and Laser Capture Microdissected Liver |
|
Data table header descriptions |
ID_REF |
|
VALUE |
'signal' a measure of the abundance of a transcript |
ABS_CALL |
the call in an absolute analysis that indicates if the transcript was present (P), absent (A), marginal (M), or no call (NC) |
Data table |
ID_REF |
VALUE |
ABS_CALL |
affx-muril2_at |
-22 |
A |
affx-muril10_at |
2 |
A |
affx-muril4_at |
-1 |
A |
affx-murfas_at |
9 |
A |
affx-biob-5_at |
124 |
P |
affx-biob-m_at |
197 |
P |
affx-biob-3_at |
160 |
P |
affx-bioc-5_at |
374 |
P |
affx-bioc-3_at |
440 |
P |
affx-biodn-5_at |
180 |
P |
affx-biodn-3_at |
1439 |
P |
affx-crex-5_at |
3302 |
P |
affx-crex-3_at |
5413 |
P |
affx-biob-5_st |
56 |
A |
affx-biob-m_st |
-2 |
A |
affx-biob-3_st |
-28 |
A |
affx-bioc-5_st |
-20 |
A |
affx-bioc-3_st |
-15 |
A |
affx-biodn-5_st |
59 |
A |
affx-biodn-3_st |
35 |
A |
Total number of rows: 8799
Table truncated, full table size 159 Kbytes.
Supplementary data files not provided |
|
|
|
|
|